Andreas Hillarp

Medicin och livsvetenskap

1. Activated Protein C Resistance 100%
2. Factor V 73%
3. Venous Thrombosis 60%
4. von Willebrand Factor 58%
5. Prothrombin 54%
6. Protein C 54%
7. Protein S 54%
8. von Willebrand Diseases 54%
9. Protein S Deficiency 53%
10. Prothrombin Time 53%
11. Factor VIII 43%
12. Hemophilia A 41%
13. Serum Amyloid P-Component 41%
14. Mutation 38%
15. Thrombosis 38%
16. Factor Xa Inhibitors 37%
17. Anticoagulants 36%
18. factor V Leiden 34%
19. Aspirin 30%
20. Thrombophilia 30%
21. Lupus Coagulation Inhibitor 29%
22. Alleles 27%
23. International Normalized Ratio 26%
24. Hemorrhage 25%
25. Partial Thromboplastin Time 25%
26. Autoantibodies 24%
27. Complement Factor H 23%
28. Complement C4b-Binding Protein 22%
29. Semen 21%
30. Warfarin 21%
31. Atypical Hemolytic Uremic Syndrome 19%
32. Genes 19%
33. Calibration 19%
34. nonacog beta pegol 18%
35. Blood Platelets 17%
36. recombinant factor VIII N8 17%
37. Haplotypes 17%
38. factor H-related protein 1 17%
39. Spermatozoa 16%
40. Longitudinal Studies 16%
41. Rivaroxaban 15%
42. Antibody Formation 15%
43. Factor Va 15%
44. Venous Thromboembolism 15%
45. apixaban 14%
46. Phenotype 14%
47. Point Mutation 14%
48. edoxaban 14%
49. Complement Inactivating Agents 13%
50. Antithrombin Proteins 13%